Ian Hampson

Dr. Hampson has had over 35 years of experience in cancer research since obtaining his Ph.D. studying the biochemistry of complex carbohydrates at the University of Manchester Paterson Laboratories in 1982. He has developed the pathology of angiogenesis which was best exemplified by a landmark paper in Science in 1985 "Angiogenesis induced by degradation products of hyaluronic acid" which now has over 1000 citations. In 1997 he took up my current post of senior lecturer in gynecological oncology at the University of Manchester, was promoted to Reader in 2013, and Chair of Viral Oncology in 2017. He discovered a new use for the HIV drug lopinavir as a treatment for HPV-related cervical dysplasia. Subsequently carrying out preclinical work on this indication which resulted in phase 1 clinical trial in Nairobi (Hampson et al 2016, PloS One).